title: Hypophysectomy and hormonal therapy modulate mK1-immunoreactive duct cells in the mice sublingual glands.
abstract: The immunocytochemical localization of a true tissue kallikrein, mK1, in mouse sublingual glands (SLGs) was examined following hypophysectomy and hormonal replacement therapy. In the glands of intact mice (14 weeks of age), mK1 was detected in the striated ducts (SDs). Full-fledged granular cells were scattered in the SDs of male mice (but not in those of female mice), showing a cellular mosaic distribution of mK1 with some being positive and others being negative. mK1 was also detected in transitional-type granular cells, though the secretory granules were too small and scarce to be visible by a light microscopy. Hypophysectomy in male mice resulted in the atrophy and loss of secretory granules in many SD cells. Granulation recovered after the repeated injection of 5alpha-dihydrotestosterone (DHT), 3,5,3'-triiodo-L: thyronine (T3), and dexamethasone (Dex), given either alone or in combination to the hypophysectomized mice. The concomitant injection of DHT and T3, with or without Dex, resulted in the reappearance of the full-fledged granular cells, only some of which were mK1-positive. Electron microscopy revealed mK1 to be present exclusively in the secretory granules of these mK1-positive cells, and no ultrastructural differences were observed between mK1-positive and mK1-negative full-fledged granular cells. These results show that the differentiation of the granular cell phenotype in the mouse SLG duct system requires the concomitant action of androgen and thyroid hormone and retards mK1 synthesis.
authors: Department of Histology, The Nippon Dental University School of Life Dentistry, Tokyo, 102-8159, Japan. kurab-fm@tky.ndu.ac.jp
authors: Shingo
authors: S
authors: Kurabuchi
authors: Edward W
authors: EW
authors: Gresik
authors: Chenjuan
authors: C
authors: Yao
authors: Kazuo
authors: K
authors: Hosoi
mesh_terms: D000818:Animals; D003907:Dexamethasone / Q000627:therapeutic use*; D013196:Dihydrotestosterone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D020249:Hormone Replacement Therapy; D007016:Hypophysectomy; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D022142:Secretory Vesicles / Q000378:metabolism* / Q000648:ultrastructure*; D012727:Sex Characteristics; D013361:Sublingual Gland / Q000378:metabolism* / Q000648:ultrastructure*; D020840:Tissue Kallikreins / Q000096:biosynthesis*; D014284:Triiodothyronine / Q000627:therapeutic use*
chemical_list: D005938:Glucocorticoids; D014284:Triiodothyronine; D013196:Dihydrotestosterone; D003907:Dexamethasone; D020840:Tissue Kallikreins